WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992004055) IMMUNOSUPPRESSANT COMPOSITION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/004055    International Application No.:    PCT/AU1991/000414
Publication Date: 19.03.1992 International Filing Date: 05.09.1991
Chapter 2 Demand Filed:    26.03.1992    
IPC:
A61K 31/445 (2006.01), A61K 31/52 (2006.01), A61K 31/57 (2006.01), A61K 38/13 (2006.01), A61K 39/395 (2006.01)
Applicants: THE AUSTRALIAN NATIONAL UNIVERSITY [AU/AU]; Acton, ACT 2601 (AU) (For All Designated States Except US).
PEPTIDE TECHNOLOGY LIMITED [AU/AU]; 4-10 Inman Road, Dee Why, NSW 2099 (AU) (For All Designated States Except US).
COWDEN, William, B. [US/AU]; (AU) (For US Only).
WILLENBORG, David, O. [US/AU]; (AU) (For US Only).
PARISH, Christopher, R. [AU/AU]; (AU) (For US Only).
BOWEN, Kerry, M. [AU/AU]; (AU) (For US Only).
HIBBERD, Adrian, D. [AU/AU]; (AU) (For US Only)
Inventors: COWDEN, William, B.; (AU).
WILLENBORG, David, O.; (AU).
PARISH, Christopher, R.; (AU).
BOWEN, Kerry, M.; (AU).
HIBBERD, Adrian, D.; (AU)
Agent: SLATTERY, John, Michael; Davies & Collison, 1 Little Collins Street, Melbourne, VIC 3000 (AU)
Priority Data:
PK 2165 06.09.1990 AU
Title (EN) IMMUNOSUPPRESSANT COMPOSITION
(FR) COMPOSITION IMMUNOSUPPRESSIVE
Abstract: front page image
(EN)An immunosuppressant composition comprising: (a) at least one immunosuppressant, such as cyclosporin; and (b) and inhibitor of glycoprotein processing, such as castanospermine; together with a pharmaceutically acceptable carrier or diluent.
(FR)Composition immunosuppressive comprenant: (a) au moins un immunosuppresseur, tel que la cyclosporine; et (b) un inhibiteur de transformation des glycoprotéines, tel que la castanospermine; associés à un support ou un diluant pharmaceutiquement acceptable.
Designated States: AU, CA, JP, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)